StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Cytrx Corporation

Enter Symbol or Keywords

Two Year High in Free Cash Flow for CytRx

Stock Quote: (NCM:CYTR)

11/20/2009

0.35

0.00

0.00%

Two Year High in Free Cash Flow for CytRx

Last

Price Change

% Chg

Volume

New York, NY, November 20, 2009-Free-Cash-News reports that negative Free Cash Flow for CytRx Corporation (NASDAQ:CYTR) for its twelve months ended September 30, 2009 was $(13,253,026), a 47% improvem ... read full story

Website Address:	www.cytrx.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: CYTR

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: CYTR

08/23/2010

CytRx's EBITDA Hits Two Year Low

08/20/2010

T12-NEWS reports that the CytRx's Revenue for its 12 month ended June 30, 2010 Increased by 47.23%

08/19/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For CytRx

... more CYTR exclusives

Other News Sources: CYTR

02/06/2012

CytRx to Present at BIO CEO & Investor Conference

12/22/2011

CytRx Initiates International Phase 2b Clinical Trial with INNO-206 in Advanced Soft Tissue Sarcoma

12/12/2011

CytRx Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at ASH Conference

... more CYTR news from other sources

Daily Market Updates

02/08/2012

Stocks End Choppy Session with Modest Gains

U.S. markets ended a choppy session with modest gains as investors awaited news regarding a Greek austerity deal. It remains unclear whether Greek Prime Minister Lucas Papademos can get politicians to accept the tough austerity policies. According to ... read full story